Prostaglandin E2-induced inflammation: Relevance of prostaglandin e receptors

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1851, Issue 4, 2015, Pages 414-421

  Kawahara, Kohichi ^a   Hohjoh, Hirofumi ^a   Inazumi, Tomoaki ^a,b   Tsuchiya, Soken ^a,b   Sugimoto, Yukihiko ^a,b  

^a KUMAMOTO UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Helper T cell; Irritant contact dermatitis; Mast cell; Multiple sclerosis; Prostanoid

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR BETA; INTERLEUKIN 6; LEUKOTRIENE B4 RECEPTOR; POLYUNSATURATED FATTY ACID; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E RECEPTOR 1; PROSTAGLANDIN E RECEPTOR 3; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN E2; ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E RECEPTOR 2;

BLOOD VESSEL PERMEABILITY; CELL ACTIVATION; CELL EXPANSION; CYTOKINE PRODUCTION; FATTY ACID METABOLISM; HELPER CELL; HISTAMINE RELEASE; IMMUNOREGULATION; INFLAMMATION; MAST CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TH17 CELL; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DESIGN; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOLECULARLY TARGETED THERAPY; STRUCTURE ACTIVITY RELATION;

MUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; DINOPROSTONE; DRUG DESIGN; HUMANS; INFLAMMATION; LYMPHOCYTE ACTIVATION; MAST CELLS; MOLECULAR STRUCTURE; MOLECULAR TARGETED THERAPY; RECEPTORS, PROSTAGLANDIN E; RECEPTORS, PROSTAGLANDIN E, EP2 SUBTYPE; RECEPTORS, PROSTAGLANDIN E, EP3 SUBTYPE; RECEPTORS, PROSTAGLANDIN E, EP4 SUBTYPE; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84922485401     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2014.07.008     Document Type: Review

References (64)

1. W.L. Smith, and R.C. Murphy The eicosanoid: cyclooxygenase, lipoxygenase, and epoxygenase pathways D.E. Vance, J.E. Vance, Biochemistry of Lipids, Lipoproteins and Membranes 4th ed. 2002 Elsevier Science B.V. Amsterdam 341 371
2. W.L. Smith, D.L. DeWitt, and R.M. Garavito Cyclooxygenases: structural, cellular and molecular biology Annu. Rev. Biochem. 69 2000 149 182
3. Y. Sugimoto, and S. Narumiya Prostaglandin E receptors J. Biol. Chem. 282 2007 11613 11617
4. D.F. Woodward, R.L. Jones, and S. Narumiya International Union of Basic and Clinical Pharmacology. LXXXIII: Classification of prostanoid receptors, updating 15 years of progress Pharmacol. Rev. 63 2011 471 538
5. R.J. Helliwell, L.F. Adams, and M.D. Mitchell Prostaglandin synthases: recent developments and a novel hypothesis Prostaglandins Leukot. Essent. Fatty Acids 70 2004 101 113
6. R.A. Coleman, W.L. Smith, and S. Narumiya Classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes Pharmacol. Rev. 46 1994 205 229
7. S. Narumiya, Y. Sugimoto, and F. Ushikubi Prostanoid receptors: structures, properties, and functions Physiol. Rev. 79 1999 1193 1226
8. 2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2 J. Exp. Med. 193 2001 255 261
9. T. Hirata, and S. Narumiya Prostanoids as regulators of innate and adaptive immunity Adv. Immunol. 116 2012 143 174
10. 2 induced functional expression of early growth response factor-1 by EP4, but not EP2, prostanoid receptors via the phosphatidylinositol 3-kinase and extracellular signal-regulated kinases J. Biol. Chem. 278 2003 12151 12156
11. F.G. Buchanan, D.L. Gorden, P. Matta, Q. Shi, L.M. Matrisian, and R.N. DuBois Role of β-arrestin 1 in the metastatic progression of colorectal cancer Proc. Natl. Acad. Sci. U. S. A. 103 2006 1492 1497
12. K.S. Chun, H.C. Lao, C.S. Trempus, M. Okada, and R. Langenbach The prostaglandin receptor EP2 activates multiple signaling pathways and β-arrestin1 complex formation during mouse skin papilloma development Carcinogenesis 30 2009 1620 1627
13. 4: metabolism and signal transduction Arch. Biochem. Biophys. 385 2001 231 241
14. M. Perretti, and A. Ahluwalia The microcirculation and inflammation: site of action for glucocorticoids Microcirculation 7 2000 147 161
15. T. Kawai, and S. Akira Toll-like receptors and their crosstalk with other innate receptors in infection and immunity Immunity 34 2011 637 650
16. T. Meyer, E. Stockfleth, and E. Christophers Immune response profiles in human skin Br. J. Dermatol. 157 Suppl. 2 2007 1 7
17. M.J. Stables, and D.W. Gilroy Old and new generation lipid mediators in acute inflammation and resolution Prog. Lipid Res. 50 2011 35 51
18. S. Moncada, S.H. Ferreira, and J.R. Vane Prostaglandins, aspirin-like drugs and the oedema of inflammation Nature 246 1973 217 219
19. T.J. Williams, and J. Morley Prostaglandins as potentiators of increased vascular permeability in inflammation Nature 246 1973 215 217
20. T.S. Rao, J.L. Currie, A.F. Shaffer, and P.C. Isakson Comparative evaluation of arachidonic acid (AA)- and tetradecanoylphorbol acetate (TPA)-induced dermal inflammation Inflammation 17 1993 723 741
21. 2 in acute cutaneous inflammation J. Immunol. 173 2004 1321 1326
22. 2-EP3 signaling induces inflammatory swelling by mast cell activation J. Immunol. 192 2014 1130 1137
23. J.S. Marshall Mast-cell responses to pathogens Nat. Rev. Immunol. 4 2004 787 799
24. S.J. Galli, and M. Tsai Mast cells in allergy and infection: versatile effector and regulatory cells in innate and adaptive immunity Eur. J. Immunol. 40 2010 1843 1851
25. C.L. Chan, R.L. Jones, and H.Y. Lau Characterization of prostanoid receptors mediating inhibition of histamine release from anti-IgE-activated rat peritoneal mast cells Br. J. Pharmacol. 129 2000 589 597
26. X.S. Wang, and H.Y. Lau Prostaglandin E potentiates the immunologically stimulated histamine release from human peripheral blood-derived mast cells through EP1/EP3 receptors Allergy 61 2006 503 506
27. Y. Baba, K. Nishida, Y. Fujii, T. Hirano, M. Hikida, and T. Kurosaki Essential function for the calcium sensor STIM1 in mast cell activation and anaphylactic responses Nat. Immunol. 9 2008 81 88
28. H.S. Kuehn, M. Rådinger, J.M. Brown, K. Ali, B. Vanhaesebroeck, M.A. Beaven, D.D. Metcalfe, and A.M. Gilfillan Btk-dependent Rac activation and actin rearrangement following FcεRI aggregation promotes enhanced chemotactic responses of mast cells J. Cell Sci. 123 2010 2576 2585
29. K. Nishida, S. Yamasaki, A. Hasegawa, A. Iwamatsu, H. Koseki, and T. Hirano Gab2, via PI-3K, regulates ARF1 in FcεRI-mediated granule translocation and mast cell degranulation J. Immunol. 187 2011 932 941
30. 2 that differentially modulate activation responses Blood 107 2006 3243 3250
31. 2 and nitric oxide mediate the acute inflammatory (erythemal) response to topical 5-aminolaevulinic acid photodynamic therapy in human skin Br. J. Dermatol. 169 2013 645 652
32. A. Dudeck, J. Dudeck, J. Scholten, A. Petzold, S. Surianarayanan, A. Köhler, K. Peschke, D. Vöhringer, C. Waskow, T. Krieg, W. Müller, A. Waisman, K. Hartmann, M. Gunzer, and A. Roers Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens Immunity 34 2011 973 984
33. J. Zhu, and W.E. Paul CD4 T cells: fates, functions, and faults Blood 112 2008 1557 1569
34. H2 hypothesis of T cell-mediated tissue damage Nat. Med. 13 2007 139 145
35. H17 cells Annu. Rev. Immunol. 27 2009 485 517
36. H17 J. Exp. Med. 205 2008 1517 1522
37. G. Bouma, and W. Strober The immunological and genetic basis of inflammatory bowel disease Nat. Rev. Immunol. 3 2003 521 533
38. M.A. Lowes, A.M. Bowcock, and J.G. Krueger Pathogenesis and therapy of psoriasis Nature 445 2007 866 873
39. J.S. Goodwin, and J. Ceuppens Regulation of the immune response by prostaglandins J. Clin. Immunol. 3 1983 295 315
40. T. Vang, V. Sundvold, F.O. Levy, B.S. Skålhegg, V. Hansson, T. Mustelin, and K. Tasken Activation of the COOH-terminal Src kinase (Csk) by cAMP-dependent protein kinase inhibits signaling through the T cell receptor J. Exp. Med. 193 2001 497 507
41. F. Hasler, H.G. Bluestein, N.J. Zvaifler, and L.B. Epstein Analysis of the defects responsible for the impaired regulation of EBV-induced B cell proliferation by rheumatoid arthritis lymphocytes. II. Role of monocytes and the increased sensitivity of rheumatoid arthritis lymphocytes to prostaglandin E J. Immunol. 131 1983 768 772
42. H1 lymphokines but not of Th2 lymphokines J. Immunol. 146 1991 108 113
43. K.N. Gold, C.M. Weyand, and J.J. Goronzy Modulation of helper T cell function by prostaglandins Arthritis Rheum. 37 1994 925 933
44. 2 critically depends on interleukin-2 Eur. J. Immunol. 25 1995 59 63
45. S.G. Harris, J. Padilla, L. Koumas, D. Ray, and R.P. Phipps Prostaglandins as modulators of immunity Trends Immunol. 23 2002 144 150
46. 2 that regulate cellular immune responses in the mouse J. Clin. Invest. 108 2001 1229 1235
47. X. Li, F. Murray, N. Koide, J. Goldstone, S.M. Dann, J. Chen, S. Bertin, G. Fu, L.S. Weinstein, M. Chen, M. Corr, L. Eckmann, P.A. Insel, and E. Raz Divergent requirement for Gαs and cAMP in the differentiation and inflammatory profile of distinct mouse Th subsets J. Clin. Invest. 122 2012 963 973
48. C.T. Weaver, R.D. Hatton, P.R. Mangan, and L.E. Harrington IL-17 family cytokines and the expanding diversity of effector T cell lineages Annu. Rev. Immunol. 25 2007 821 852
49. 2 promotes Th1 differentiation via synergistic amplification of IL-12 signalling by cAMP and PI3-kinase Nat. Commun. 4 2013 1685
50. 2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion Nat. Med. 15 2009 633 640
51. E. Bjørgo, S.A. Solheim, H. Abrahamsen, G.S. Baillie, K.M. Brown, T. Berge, K. Okkenhaug, M.D. Houslay, and K. Taskén Cross talk between phosphatidylinositol 3-kinase and cyclic AMP (cAMP)-protein kinase A signaling pathways at the level of a protein kinase B/beta-arrestin/cAMP phosphodiesterase 4 complex Mol. Cell. Biol. 30 2010 1660 1672
52. 2 suppresses allergic sensitization and lung inflammation by targeting the E prostanoid 2 receptor on T cells J. Allergy Clin. Immunol. 133 2014 379 387
53. + T regulatory cells and Th17 cells Prostaglandins Leukot. Essent. Fatty Acids 80 2009 195 200
54. 2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling J. Exp. Med. 206 2009 535 548
55. 2 synergistically with interleukin-23 favors human Th17 expansion Blood 112 2008 3696 3703
56. A.V. Gorbachev, and R.L. Fairchild Induction and regulation of T-cell priming for contact hypersensitivity Crit. Rev. Immunol. 21 2001 451 472
57. V.K. Kuchroo, A.C. Anderson, H. Waldner, M. Munder, E. Bettelli, and L.B. Nicholson T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire Annu. Rev. Immunol. 20 2002 101 123
58. H. Niwa, T. Satoh, Y. Matsushima, K. Hosoya, K. Saeki, T. Niki, M. Hirashima, and H. Yokozeki Stable form of galectin-9, a Tim-3 ligand, inhibits contact hypersensitivity and psoriatic reactions: a potent therapeutic tool for Th1- and/or Th17-mediated skin inflammation Clin. Immunol. 132 2009 184 194
59. T. Korn, E. Bettelli, and M. Oukka IL-17 and Th17 cells Annu. Rev. Immunol. 27 2009 485 517
60. D. Pennino, K. Eyerich, C. Scarponi, T. Carbone, S. Eyerich, F. Nasorri, S. Garcovich, C. Traidl-Hoffmann, C. Albanesi, and A. Cavani IL-17 amplifies human contact hypersensitivity by licensing hapten nonspecific Th1 cells to kill autologous keratinocytes J. Immunol. 184 2010 4880 4888
61. H. Lassmann, and R.M. Ransohoff The CD4-Th1 model for multiple sclerosis: a critical [correction of crucial] re-appraisal Trends Immunol. 25 2004 132 137
62. Y. Komiyama, S. Nakae, T. Matsuki, A. Nambu, H. Ishigame, S. Kakuta, K. Sudo, and Y. Iwakura IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis J. Immunol. 177 2006 566 573
63. H. Park, Z. Li, X.O. Yang, S.H. Chang, R. Nurieva, Y.H. Wang, Y. Wang, L. Hood, Z. Zhu, Q. Tian, and C. Dong A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 Nat. Immunol. 6 2005 1133 1141
64. 2-EP4 signaling in mouse experimental autoimmune encephalomyelitis Proc. Natl. Acad. Sci. U. S. A. 107 2010 12233 12238